Which kidney number the label assumed decides the first half; body composition and a child's faster clearance decide the second, all worked on composite values for MN553 Unit 8. Searches like "mn 553 unit 8 assignment example", "mn553 unit 8 sample" and "mn553 unit 8 example" land here.
Two Kidney Numbers for One Woman: A Lifespan Dosing Analysis of a Renally Cleared Composite Agent From Age 83 to Age 4
[Student Name]
Purdue University Global
MN553: Advanced Pharmacology
Unit 8 Assignment
[Instructor Name]
[Date]
Agents R and S are composite compounds with invented values, and both patients are composites. Nothing here is a prescribing instruction for a real drug.
Part 1: Two Kidney Numbers for One Woman
A composite 83-year-old retired seamstress weighs 49 kg and has a serum creatinine of 1.0 mg/dL. Her laboratory report shows an estimated glomerular filtration rate (eGFR) of 56 mL/min/1.73 m2, calculated with the 2021 CKD-EPI creatinine equation (Inker et al., 2021).
Calculation box 1. Cockcroft-Gault creatinine clearance = [(140 minus age) x weight in kg] / (72 x serum creatinine) x 0.85 for women. [(140 minus 83) x 49] / (72 x 1.0) x 0.85 = (57 x 49) / 72 x 0.85 = 2,793 / 72 x 0.85 = 38.8 x 0.85 = 33.0 mL/min (Cockcroft & Gault, 1976).
The two numbers describe the same kidneys and differ by 23 units. Three reasons explain the gap. First, eGFR is indexed to a standard body surface area of 1.73 m2, while Cockcroft-Gault gives an absolute clearance in mL/min. A small woman of 49 kg has a body surface area well below 1.73 m2, so her indexed value runs higher than her actual clearance. Second, the Cockcroft-Gault equation includes weight directly, and her low weight lowers the result. Third, the two equations were built from different populations and methods. Many drug labels were written from studies that grouped patients by Cockcroft-Gault clearance, so when a label gives an adjustment threshold, it usually refers to her 33, not her 56. Using the eGFR would place her above a common adjustment threshold of 50 mL/min, while her clearance places her well below it.
Both numbers rest on creatinine, and creatinine can flatter her. Creatinine comes from muscle, and an 83-year-old woman of 49 kg has little muscle mass, so her creatinine is low for her true kidney function. Her actual clearance may be lower than 33. The analysis therefore uses 33 as an upper estimate and names monitoring that would show if the adjustment was not enough.
Part 2: Clearance as a Fraction of Normal for Agent R
Agent R is a composite drug eliminated 90 percent unchanged by the kidney and 10 percent by the liver. In an adult with normal renal function, taken as a creatinine clearance of 100 mL/min, total clearance of Agent R is 6 L/h, and the usual regimen is 500 mg every 8 hours.
Calculation box 2. Fraction of normal clearance = nonrenal fraction + (renal fraction x her clearance ratio) = 0.1 + (0.9 x 33 / 100) = 0.1 + 0.297 = 0.397, or about 40 percent. Her estimated total clearance of Agent R = 6 L/h x 0.397 = 2.4 L/h.
Because the average steady-state concentration depends on dosing rate divided by clearance, keeping her average concentration at the level reached in a typical adult requires a dosing rate about 40 percent of normal (Rowland & Tozer, 2011). Two ways achieve that. Option A reduces the amount and keeps the interval: 500 mg x 0.397 = about 200 mg every 8 hours. Option B keeps the amount and lengthens the interval: 8 hours / 0.397 = about 20 hours, so 500 mg once daily would be close. Option A gives smaller swings between peak and trough; Option B gives higher peaks and lower troughs. The choice depends on whether Agent R's effect follows peak concentration or time above a threshold, which a real drug's labeling would specify.
Part 3: What Else Age Changes
Kidney function is not the only thing that changes with age. Body composition shifts: the proportion of fat rises and the proportion of water and lean mass falls. For a fat-soluble drug, this increases the volume of distribution (Mangoni & Jackson, 2004).
Calculation box 3. Agent S, a composite lipophilic drug, has a clearance of 10 L/h and a volume of 100 L in a young adult, so its half-life is 0.693 x 100 / 10 = 6.9 hours. In this woman, with the same clearance but a volume of 150 L, the half-life is 0.693 x 150 / 10 = 10.4 hours. Elimination is intact, yet the drug lingers 50 percent longer, and a clearance calculation alone would never show it.
Protein binding changes too. Her albumin is 3.1 g/dL. For a highly bound acidic composite drug that is 98 percent bound at an albumin of 4.0 g/dL, the unbound fraction rises roughly in proportion to the fall in albumin, from about 2 percent toward about 2.6 percent. For most drugs, clearance of the unbound drug adjusts and the unbound concentration settles near its usual level, but a total drug level on a laboratory report will look lower than the effect suggests. The practical point is that her measured levels must be read with her albumin in mind.
Part 4: The Other End of Life
Agent R in a 4-year-old boy weighing 16 kg behaves differently. By this age, glomerular filtration has reached adult values when corrected for size, and young children clear many renally eliminated drugs faster per kilogram than adults do (Kearns et al., 2003). For Agent R, the adult clearance of 6 L/h in a 70 kg person is 0.086 L/h per kg; the child's is estimated at 0.12 L/h per kg, or 1.9 L/h in total.
Calculation box 4. A weight-based regimen of 10 mg/kg every 8 hours gives 160 mg per dose for this boy. Weight-based arithmetic must stop at the adult maximum. For a 12-year-old weighing 55 kg, the same formula gives 550 mg, which exceeds the adult dose of 500 mg; the calculated amount is capped at 500 mg.
The two ends of life point in opposite directions for Agent R. The older woman needs about 40 percent of the adult dosing rate, and the child needs more per kilogram than an adult but never more in total than an adult maximum.
Monitoring That Would Confirm Each Adjustment
For the older woman, the adjustment would be checked by a trough level of Agent R after four to five half-lives, by repeat creatinine at one week, and by watching for adverse effects that would signal accumulation. For the child, response to treatment and any adverse effects would be the main measures. In both, the calculation is an estimate, and monitoring is what shows whether it was right. If her trough came back higher than expected, the most likely explanation would be that creatinine had overstated her kidney function, as Part 1 warned, and the next step would be a further reduction guided by the measured level rather than a new estimate. A measured cystatin C, which does not depend on muscle mass, could also give a second estimate of her kidney function if the two approaches disagreed.
References
Cockcroft, D. W., & Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron, 16(1), 31-41. https://doi.org/10.1159/000180580
Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., Crews, D. C., Doria, A., Estrella, M. M., Froissart, M., Grams, M. E., Greene, T., Grubb, A., Gudnason, V., Gutiérrez, O. M., Kalil, R., Karger, A. B., Mauer, M., Navis, G., ... Levey, A. S. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. New England Journal of Medicine, 385(19), 1737-1749. https://doi.org/10.1056/NEJMoa2102953
Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., & Kauffman, R. E. (2003). Developmental pharmacology: Drug disposition, action, and therapy in infants and children. New England Journal of Medicine, 349(12), 1157-1167. https://doi.org/10.1056/NEJMra035092
Mangoni, A. A., & Jackson, S. H. D. (2004). Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. British Journal of Clinical Pharmacology, 57(1), 6-14. https://doi.org/10.1046/j.1365-2125.2003.02007.x
Rowland, M., & Tozer, T. N. (2011). Clinical pharmacokinetics and pharmacodynamics: Concepts and applications (4th ed.). Lippincott Williams and Wilkins.
How this MN553 Unit 8 example is structured
Each part answers one question about a number: where it comes from, what it changes, and what would confirm the change was right. The kidney section refuses the shortcut of treating eGFR and clearance as interchangeable, and it states the uncertainty honestly, since Cockcroft-Gault itself rests on creatinine, which runs low in older adults with little muscle and can flatter the estimate. Agent R's adjustment is shown as a fraction of normal clearance, 0.1 plus 0.9 times her clearance ratio, so the grader can follow each term. The fat-soluble composite illustrates a change that clearance calculations miss entirely: a larger volume stretches half-life even when elimination is intact. The child's section closes the analysis with a caution about mg/kg arithmetic that must stop at the adult maximum.
Get an MN553 Unit 8 example written to your instructions
The Unit 8 case from your MN553 section, with its lab values, ages and the rubric, is all the sample needs; composite drugs stay composite unless the prompt names real ones. Back in 24-48h and free for a first request, it shows each kidney calculation, explains which number was used and why, and caps any pediatric figure. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
MN553 Unit 8 questions, answered
Should the analysis use eGFR or Cockcroft-Gault?
Both, usually, with a reason for the one that drives the decision. Many older drug labels base their adjustment thresholds on Cockcroft-Gault clearance, while newer ones increasingly accept eGFR. Showing the two side by side and naming the label's basis is what most rubrics reward; choosing silently leaves a grader unable to tell whether the difference was understood.
Why include a child in an analysis about an older adult?
Because lifespan dosing runs in both directions, and a single composite agent shows it clearly. The older body clears the drug more slowly; a young child, past infancy, often clears it faster per kilogram. Setting the two against each other keeps the analysis about mechanisms rather than about a rule of thumb for one age group.
Can real drugs replace the composite ones?
If the prompt names them, yes, and the method is identical. The sample uses composite agents so that no figure on the page can be read as dosing advice for a real person. Where a real drug is required, the adjustment should cite its labeling or a named reference and be presented as coursework, with the amounts bracketed.